BEND3 is involved in the human-specific repression of calreticulin: Implication for the evolution of higher brain functions in human

Gene

Volumn 576, Issue 1, 2016, Pages 577-580

  Aghajanirefah, A ^a   Nguyen, L N ^a   Ohadi, M ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF SOCIAL WELFARE AND REHABILITATION SCIENCES   (Iran)

Author keywords

BEND3; Calreticulin; DNA pulldown; Human specific; Nuclear factor I

Indexed keywords

BEN DOMAIN CONTAINING 3 PROTEIN; BINDING PROTEIN; CALRETICULIN; NUCLEOTIDE; UNCLASSIFIED DRUG; BEND3 PROTEIN, HUMAN; DNA; REPRESSOR PROTEIN;

ALLELE; ARTICLE; BRAIN FUNCTION; FEMALE; GENE MUTATION; GENE REPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; ANIMAL; BRAIN; GENETICS; HELA CELL LINE; METABOLISM; MOLECULAR EVOLUTION; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; SEQUENCE HOMOLOGY;

ANIMALS; BASE SEQUENCE; BRAIN; CALRETICULIN; DNA; EVOLUTION, MOLECULAR; HELA CELLS; HUMANS; REPRESSOR PROTEINS; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 84949591394     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.10.040     Document Type: Article

References (41)

1. Aghajani A., Rahimi A., Fadai F., Ebrahimi A., Najmabadi H., Ohadi M. A point mutation at the calreticulin gene core promoter conserved sequence in a case of schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2006, 141B:294-295.
2. Arion D., Unger T., Lewis D.A., Levitt P., Mirnics K. Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol. Psychiatry 2007, 62:711-721.
3. Barbagallo B., Prescott H.A., Boyle P., Climer J., Francis M.M. A dominant mutation in a neuronal acetylcholine receptor subunit leads to motor neuron degeneration in Caenorhabditis elegans. J. Neurosci. 2010, 30:13932-13942.
4. Blomquist P., Belikov S., Wrange O. Increased nuclear factor 1 binding to its nucleosomal site mediated by sequence-dependent DNA structure. Nucleic Acids Res. 1999, 27:517-525.
5. Bown C.D., Wang J.F., Chen B., Young L.T. Regulation of ER stress proteins by valproate: therapeutic implications. Bipolar Disord. 2002, 4:145-151. Review.
6. Bozidis P., Hyphantis T., Mantas C., Sotiropoulou M., Antypa N., Andreoulakis E., Serretti A., Mavreas V., Antoniou K. HSP70 polymorphisms in first psychotic episode drug-naïve schizophrenic patients. Life Sci. 2014, 100:133-137.
7. Campbell C.E., Piper M., Plachez C., Yeh Y.T., Baizer J.S., Osinski J.M., Litwack E.D., Richards L.J., Gronostajski R.M. The transcription factor Nfix is essential for normal brain development. BMC Dev. Biol. 2008, 8:52.
8. Corson T.W., Woo K.K., et al. Cell-type specific regulation of calreticulin and Bcl-2 expression by mood stabilizer drugs. Eur. Neuropsychopharmacol. 2004, 14:143-150.
9. Cox J., Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 2008, 26:1367-1372.
10. Esmaeilzadeh-Gharehdaghi E., Banan M., Farashi S., Mirabzadeh A., Farokhashtiani T., Hosseinkhani S., et al. Support for down-tunning of the calreticulin gene in the process of human evolution. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2011, 35:1770-1773.
11. Farokhashtiani T., Mirabzadeh A., Olad Nabi M., Ghaem Magham Z., Khorram Khorshid H.R., Najmabadi H., et al. Reversion of the human calreticulin gene promoter to the ancestral type as a result of a novel psychosis-associated mutation. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2011, 35:541-544.
12. Gronostajski R.M. Roles of the NFI/CTF gene family in transcription and development. Gene 2000, 249:31-45.
13. Gupta C.N., Chen J., Liu J., Damaraju E., Wright C., Perrone-Bizzozero N.I., Pearlson G., Luo L., Michael A.M., Turner J.A., Calhoun V.D. Genetic markers of white matter integrity in schizophrenia revealed by parallel ICA. Front. Hum. Neurosci. 2015, 9:100.
14. Harris L., Genovesi L.A., Gronostajski R.M., Wainwright B.J., Piper M. Nuclear factor one transcription factors: divergent functions in developmental versus adult stem cell populations. Dev. Dyn. 2015, 244:227-238.
15. Harrison P.J., Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 2005, 10:40-68.
16. Hubner N.C., Nguyen L.N., Hornig N.C., Stunnenberg H.G. A quantitative proteomics tool to identify DNA-protein interactions in primary cells or blood. J. Proteome Res. 2015, 14:1315-1329.
17. Iwamoto K., Kato T. Gene expression profiling in schizophrenia and related mental disorders. Neuroscientist 2006, 12:349-361.
18. Jaskolski F., Normand E., Mulle C., Coussen F. Differential trafficking of GluR7 kianate receptor subunit splice variants. J. Biol. Chem. 2005, 280:22968-22976.
19. Kakiuchi C., Iwamoto K., Ishiwata M., Bundo M., Kasahara T., Kusumi I., et al. Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder. Nat. Genet. 2003, 35:171-175.
20. Kazeminasab S., Esmaeilzadeh-Gharehdaghi E., Oladnabi M., Ohadi M., Mirabzadeh A., Hosseinkhani S. Aberrant expression of activating transcription factor 6 (ATF6) in major psychiatric disorders. Psychiatry Res. 2012, 200:1086-1087.
21. Kim A.J., Shi Y., Austin R.C., Werstuck G.H. Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3. J. Cell Sci. 2005, 118:89-99.
22. Lee H.J., Woo H.G., Greenwood T.A., Kripke D.F., Kelsoe J.R. A genome-wide association study of seasonal pattern mania identifies NF1A as a possible susceptibility gene for bipolar disorder. J. Affect. Disord. 2013, 145:200-207.
23. Liu X., Xu N., Zhang S. Calreticulin is a microbial-binding molecule with phagocytosis-enhancing capacity. Fish Shellfish Immunol. 2013, 35:776-784.
24. Luo X., Weber G.A., Zheng J., Gendelman H.E., Ikezu T. C1q-calreticulin induced oxidative neurotoxicity: relevance for the neuropathogenesis of Alzheimer's disease. J. Neuroimmunol. 2003, 135:62-71.
25. Mano I., Driscoll M. Caenorhabditis elegans glutamate transporter deletion induces AMPA-receptor/adenylyl cyclase 9-dependent excitotoxicity. J. Neurochem. 2009, 108:1373-1384.
26. Mason S., Piper M., Gronostajski R.M., Richards L.J. Nuclear factor one transcription factors in CNS development. Mol. Neurobiol. 2009, 39:10-23.
27. Matigian N., Windus L., Smith H., Filipich C., Pantelis C., McGrath J., et al. Expression profiling in monozygotic twins discordant for bipolar disorder reveals dysregulation of the WNT signaling pathway. Mol. Psychiatry 2007, 12:815-825.
28. Mohrluder J., et al. Identification of calreticulin as a ligand of GABARAP by phage display screening of a peptide library. FEBS J. 2007, 274:5543-5555.
29. Narayan S., Tang B., Head S.R., Gilmartin T.J., Sutcliffe J.G., Dean B., Thomas E.A. Molecular profiles of schizophrenia in the CNS at different stages of illness. Brain Res. 2008, 1239:235-248.
30. Nunes A., Ohadi M., Rahimi A., Aghajani A., Najmabadi H., Curraisa A., et al. A mutation in the calreticulin gene promoter in a family case of schizoaffective disorder leads to its aberrant transcriptional activation. Brain Res. 2008, 1239:36-41.
31. Ohadi M., Mirabzadeh A., Esmaeilzadeh-Gharehdaghi E., Rezazadeh M., Hosseinkhanni S., Oladnabi M., Firouzabadi S.G., Darvish H. Novel evidence of the involvement of calreticulin in major psychiatric disorders. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2012, 37:276-281.
32. Olad Nabi M., Mirabzadeh A., Feizzadeh G., Khorshid H.R., Karimlou M., Yeganeh M.Z., et al. Novel mutations in the calreticulin gene core promoter and coding sequence in schizoaffective disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010, 153B:706-709.
33. Piper M., Barry G., Harvey T.J., McLeay R., Smith A.G., Harris L., Mason S., Stringer B.W., Day B.W., Wray N.R., Gronostajski R.M., Bailey T.L., Boyd A.W., Richards L.J. NFIB-mediated repression of the epigenetic factor Ezh2 regulates cortical development. J. Neurosci. 2014, 34:2921-2930.
34. Raghavan M., Wijeyesakere S.J., Peters L.R., et al. Calreticulin in the immune system: ins and outs. Trends Immunol. 2013, 34:13-21.
35. Saksouk N., Barth T.K., Ziegler-Birling C., Olova N., Nowak A., Rey E., et al. Redundant mechanisms to form silent chromatin at pericentromeric regions rely on BEND3 and DNA methylation. Mol. Cell 2014, 56:580-594.
36. Sathyan K.M., Shen Z., Tripathi V., Prasanth K.V., Prasanth S.G. A BEN-domain-containing protein associates with heterochromatin and represses transcription. J. Cell Sci. 2011, 124:3149-3163.
37. Shiheido H., Shimizu J. Basic amino acid residues located in the N-terminal region of BEND3 are essential for its nuclear localization. Biochem. Biophys. Res. Commun. 2015, 457:589-594.
38. Sodhi M.S., Simmons M., McCullumsmith R., Haroutunian V., Meador-Woodruff J.H. Glutamatergic gene expression is specifically reduced in thalamocortical projecting relay neurons in schizophrenia. Biol. Psychiatry 2011, 70:646-654.
39. Sperner-Unterweger B., Fuchs D. Schizophrenia and psychoneuroimmunology: an integrative view. Curr. Opin. Psychiatry 2015, 28:201-206.
40. Steele-Perkins G., Plachez C., Butz K.G., Yang G., Bachurski C.J., Kinsman S.L., Litwack E.D., Richards L.J., Gronostajski R.M. The transcription factor gene Nfib is essential for both lung maturation and brain development. Mol. Cell. Biol. 2005, 25:685-698.
41. Zhou B., Osinski J.M., Mateo J.L., Martynoga B., Sim F.J., Campbell C.E., Guillemot F., Piper M., Gronostajski R.M. Loss of NFIX transcription factor biases postnatal neural stem/progenitor cells towards oligodendrogenesis. Stem Cells Dev. 2015.